{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:23:30Z","timestamp":1774110210914,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ymgmr.2020.100610","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T11:57:16Z","timestamp":1590839836000},"page":"100610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency"],"prefix":"10.1016","volume":"24","author":[{"given":"Tomonori","family":"Suyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kuranobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ichimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2020.100610_bb0005","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1203\/01.PDR.0000103931.80055.06","article-title":"General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover","volume":"55","author":"Spiekerkoetter","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0010","first-page":"979","article-title":"Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits","volume":"58","author":"Ushikubo","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0015","first-page":"55","article-title":"Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan","volume":"15","author":"Yamada","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/jhg.2017.52","article-title":"Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases","volume":"62","author":"Bo","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ymgme.2009.07.011","article-title":"Clinical and molecular aspects of Japanese patients with mitochondrial trifunctional protein deficiency","volume":"98","author":"Purevsuren","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1024433100257","article-title":"Treatment of carnitine deficiency","volume":"26","author":"Winter","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s10038-018-0527-7","article-title":"Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Yamada","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10545-008-0844-7","article-title":"PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders","volume":"31","author":"Djouadi","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10545-015-9871-3","article-title":"Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate","volume":"39","author":"Djouadi","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0055","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1056\/NEJMc0806334","article-title":"Bezafibrate for an inborn mitochondrial beta-oxidation defect","volume":"360","author":"Bonnefont","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0065","first-page":"100496","article-title":"Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan; 2nd report QOL survey","volume":"20","author":"Shiraishi","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ajmg.a.36434","article-title":"Mutations in HADHB, which encodes the beta-subunit of mitochondrial trifunctional protein, cause infantile onset hypoparathyroidism and peripheral polyneuropathy","volume":"164a","author":"Naiki","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2020.100610_bb0075","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0080","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.braindev.2014.10.005","article-title":"Carnitine-acylcarnitine translocase deficiency: two neonatal cases with common splicing mutation and in vitro bezafibrate response","volume":"37","author":"Vatanavicharn","year":"2015","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.braindev.2016.08.004","article-title":"Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay","volume":"39","author":"Yamada","year":"2017","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0090","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2169\/internalmedicine.55.6288","article-title":"First Japanese case of carnitine palmitoyltransferase II deficiency with the homozygous point mutation S113L","volume":"55","author":"Shima","year":"2016","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2012.07.004","article-title":"Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay","volume":"107","author":"Yamaguchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100610_bb0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","article-title":"Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial","volume":"82","author":"Orngreen","year":"2014","journal-title":"Neurology"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920300562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:50:36Z","timestamp":1762001436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920300562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"alternative-id":["S2214426920300562"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100610","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100610"}}